30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Aimmune Therapeutics Inc (AIMT)

Track

Stock chart
Ticker: AIMT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Societe des Produits Nestle S.A.
2 purchases — total 1,867,046,402 USD
Buy 13 Oct 2020
Value US$2,135,656.62 | Price 354.97 | Shares 73,388
Buy 13 Oct 2020
Value US$3,337,608.74 | Price 451.38 | Shares 32,490
Buy 18 Mar 2020
Value US$1,256,198.86 | Price 448.03 | Shares 77,492
Buy 17 Mar 2020
Value US$101,050.50 | Price 11.50 | Shares 8,787
Buy 17 Mar 2020
Value US$1,139,650.00 | Price 11.40 | Shares 100,000
Buy 13 Mar 2020
Value US$44,265.90 | Price 14.76 | Shares 3,000
Buy 12 Mar 2020
Value US$15,100.00 | Price 15.10 | Shares 1,000
Buy 10 Mar 2020
Value US$49,934.10 | Price 18.74 | Shares 2,665
Buy 9 Mar 2020
Value US$18,970.00 | Price 18.97 | Shares 1,000
Buy 7 Feb 2020
Value US$168,032,048.95 | Price 319.68 | Shares 525,634
Buy 7 Feb 2020
Value US$31,970,000.00 | Price 31.97 | Shares 1,000,000
Planned sale 16 Jan 2020
Value US$14,800.00 | Price 37.00 | Shares 400
Planned sale 2 Jan 2020
Value US$700,038.00 | Price 35.00 | Shares 20,000
Planned sale 26 Dec 2019
Value US$330,322.00 | Price 33.03 | Shares 10,000
Planned sale 9 Dec 2019
Value US$600,716.00 | Price 30.04 | Shares 20,000
Buy 18 Sep 2019
Value US$34,976.68 | Price 22.57 | Shares 1,550
Buy 28 Nov 2018
Value US$98,000,002.83 | Price 30.27 | Shares 3,237,529
Sale 19 Nov 2018
Value US$1,201,600.00 | Price 30.04 | Shares 40,000
Buy 19 Nov 2018
Value US$1,378.00 | Price 27.56 | Shares 50
Buy 19 Nov 2018
Value US$99,208.80 | Price 27.56 | Shares 3,600
Planned buy 13 Jun 2018
Value US$48,663.04 | Price 30.41 | Shares 1,600
Planned sale 11 Jun 2018
Value US$908,300.70 | Price 30.83 | Shares 29,457
Planned sale 8 Jun 2018
Value US$1,292,511.04 | Price 30.70 | Shares 42,106
Planned sale 7 Jun 2018
Value US$15,790.00 | Price 31.58 | Shares 500
Planned sale 7 Jun 2018
Value US$993,320.76 | Price 30.95 | Shares 32,098
Planned sale 6 Jun 2018
Value US$950,370.91 | Price 31.20 | Shares 30,465
Planned sale 5 Jun 2018
Value US$1,235,834.69 | Price 31.83 | Shares 38,825
Planned sale 4 Jun 2018
Value US$85,519.49 | Price 32.74 | Shares 2,612
Planned sale 4 Jun 2018
Value US$1,997,836.09 | Price 31.84 | Shares 62,740
Planned sale 1 Jun 2018
Value US$82,898.63 | Price 33.19 | Shares 2,498
Planned sale 1 Jun 2018
Value US$1,913,094.33 | Price 32.59 | Shares 58,699
Planned sale 22 May 2018
Value US$54,384.00 | Price 33.00 | Shares 1,648
Planned sale 22 May 2018
Value US$54,384.00 | Price 33.00 | Shares 1,648
Planned sale 5 Mar 2018
Value US$25,617.97 | Price 36.60 | Shares 700
Planned sale 5 Mar 2018
Value US$33,674.00 | Price 35.52 | Shares 948
Planned sale 5 Mar 2018
Value US$69,375.00 | Price 37.00 | Shares 1,875
Planned sale 1 Mar 2018
Value US$59,811.70 | Price 33.10 | Shares 1,807
Buy 26 Feb 2018
Value US$30,000,000.00 | Price 32.00 | Shares 937,500
Buy 26 Feb 2018
Value US$100,000.00 | Price 32.00 | Shares 3,125
Buy 26 Feb 2018
Value US$960,000.00 | Price 32.00 | Shares 30,000
Buy 26 Feb 2018
Value US$300,000.00 | Price 32.00 | Shares 9,375
Buy 22 Feb 2018
Value US$498,976.00 | Price 32.00 | Shares 15,593
Buy 22 Feb 2018
Value US$300,000.00 | Price 32.00 | Shares 9,375
Planned sale 5 Feb 2018
Value US$59,113.76 | Price 35.87 | Shares 1,648
Planned sale 1 Feb 2018
Value US$152,702.92 | Price 35.58 | Shares 4,292
Planned sale 1 Feb 2018
Value US$80,385.00 | Price 34.95 | Shares 2,300
Planned sale 24 Jan 2018
Value US$71,531.25 | Price 38.15 | Shares 1,875
Planned sale 16 Jan 2018
Value US$397,320.00 | Price 40.00 | Shares 9,933
Planned sale 12 Jan 2018
Value US$1,071,360.00 | Price 40.00 | Shares 26,784
Planned sale 4 Jan 2018
Value US$61,519.84 | Price 37.33 | Shares 1,648
Planned sale 2 Jan 2018
Value US$22,651.98 | Price 37.75 | Shares 600
Planned sale 2 Jan 2018
Value US$905,715.80 | Price 37.12 | Shares 24,400
Planned sale 2 Jan 2018
Value US$11,358.99 | Price 37.86 | Shares 300
Planned sale 2 Jan 2018
Value US$917,022.08 | Price 37.13 | Shares 24,700
Planned sale 2 Jan 2018
Value US$22,629.32 | Price 37.78 | Shares 599
Planned sale 2 Jan 2018
Value US$905,811.48 | Price 37.12 | Shares 24,401
Planned sale 2 Jan 2018
Value US$59,367.32 | Price 37.08 | Shares 1,601
Planned sale 2 Jan 2018
Value US$185,222.81 | Price 37.12 | Shares 4,990
Planned sale 27 Dec 2017
Value US$131,320.00 | Price 40.00 | Shares 3,283
Planned sale 26 Dec 2017
Value US$140,949.36 | Price 39.15 | Shares 3,600
Planned sale 26 Dec 2017
Value US$247,848.32 | Price 38.73 | Shares 6,400
Planned sale 26 Dec 2017
Value US$47,133.96 | Price 39.28 | Shares 1,200
Planned sale 26 Dec 2017
Value US$341,662.64 | Price 38.83 | Shares 8,800
Planned sale 26 Dec 2017
Value US$27,478.99 | Price 39.26 | Shares 700
Planned sale 26 Dec 2017
Value US$167,239.21 | Price 38.80 | Shares 4,310
Planned sale 26 Dec 2017
Value US$58,846.95 | Price 39.23 | Shares 1,500
Planned sale 26 Dec 2017
Value US$427,043.10 | Price 38.82 | Shares 11,000
Planned sale 26 Dec 2017
Value US$58,875.00 | Price 39.25 | Shares 1,500
Planned sale 26 Dec 2017
Value US$427,114.60 | Price 38.83 | Shares 11,000
Planned sale 26 Dec 2017
Value US$70,605.00 | Price 39.23 | Shares 1,800
Planned sale 26 Dec 2017
Value US$415,321.57 | Price 38.82 | Shares 10,700
Planned sale 26 Dec 2017
Value US$58,878.00 | Price 39.25 | Shares 1,500
Planned sale 26 Dec 2017
Value US$427,089.30 | Price 38.83 | Shares 11,000
Planned sale 26 Dec 2017
Value US$73,950.00 | Price 39.44 | Shares 1,875
Planned sale 4 Dec 2017
Value US$73,685.96 | Price 38.66 | Shares 1,906
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-10-15 2020-10-13 B Purchase
2.9
Societe des Produits Nestle S.A.
Large shareholder
73,388 +32.6%
354.97
US$2,135,657 		73,388 +32.6% 354.97 US$2,135,657
2020-10-15 2020-10-13 B Purchase
2.9
Societe des Produits Nestle S.A.
Large shareholder
32,490 +20.8%
451.38
US$3,337,609 		32,490 +20.8% 451.38 US$3,337,609
2020-03-19 2020-03-18 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
77,492 -25.1%
448.03
US$1,256,199 		77,492 -25.1% 448.03 US$1,256,199
2020-03-19 2020-03-17 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
8,787 +19.3%
11.50
US$101,050 		8,787 +19.3% 11.50 US$101,050
2020-03-19 2020-03-17 B Purchase
3.6
ENRIGHT PATRICK G
Non-Executive Director
100,000 +1.7%
11.40
US$1,139,650 		100,000 +1.7% 11.40 US$1,139,650
2020-03-17 2020-03-13 B Purchase
Oxtoby Andrew

Chief Commercial Officer

Officer
3,000 +13.6%
14.76
US$44,266 		3,000 +13.6% 14.76 US$44,266
2020-03-12 2020-03-12 B Purchase
3.3
BJERKHOLT ERIC

Chief Financial Officer

Officer
1,000 +2.4%
15.10
US$15,100 		1,000 +2.4% 15.10 US$15,100
2020-03-10 2020-03-10 B Purchase
Dallas Jayson Donald Alexander

President and CEO

Executive Director
2,665 +2.2%
18.74
US$49,934 		2,665 +2.2% 18.74 US$49,934
2020-03-10 2020-03-09 B Purchase
3.3
BJERKHOLT ERIC

Chief Financial Officer

Officer
1,000 +2.4%
18.97
US$18,970 		1,000 +2.4% 18.97 US$18,970
2020-04-24 2020-02-07 B Purchase
2.9
Societe des Produits Nestle S.A.
Large shareholder
525,634 +inf%
319.68
US$168,032,049 		525,634 +inf% 319.68 US$168,032,049
2020-04-24 2020-02-07 B Purchase
2.9
Societe des Produits Nestle S.A.
Large shareholder
1,000,000 +8.5%
31.97
US$31,970,000 		1,000,000 +8.5% 31.97 US$31,970,000
2020-01-21 2020-01-16 PlS Planned sale
Sheehy Douglas T.

See Remarks
400 -0.9%
37.00
US$14,800 		400 -0.9% 37.00 US$14,800
2020-01-03 2020-01-02 PlS Planned sale
ADELMAN DANIEL C MD

Chief Medical Officer
20,000 -48.5%
35.00
US$700,038 		20,000 -48.5% 35.00 US$700,038
2019-12-30 2019-12-26 PlS Planned sale Sheehy Douglas T.

See Remarks

Officer
10,000 -18.0%
33.03
US$330,322 		10,000 -18.0% 33.03 US$330,322
2019-12-11 2019-12-09 PlS Planned sale ADELMAN DANIEL C MD

Chief Medical Officer

Officer
20,000 -48.5%
30.04
US$600,716 		20,000 -48.5% 30.04 US$600,716
2019-09-20 2019-09-18 B Purchase
3.3
BJERKHOLT ERIC

Chief Financial Officer
1,550 +4.8%
22.57
US$34,977 		1,550 +4.8% 22.57 US$34,977
2020-04-24 2018-11-28 B Purchase
Nestle Health Science US Holdings, Inc.
Large shareholder
3,237,529 +38.1%
30.27
US$98,000,003 		3,237,529 +38.1% 30.27 US$98,000,003
2018-11-21 2018-11-19 S Sale Barrowcliffe Susan E.

General Manager, Europe

Officer
40,000 -81.0%
30.04
US$1,201,600 		40,000 -81.0% 30.04 US$1,201,600
2018-11-19 2018-11-19 B Purchase Dallas Jayson Donald Alexander

President and CEO

Executive Director
50 +0.1%
27.56
US$1,378 		50 +0.1% 27.56 US$1,378
2018-11-19 2018-11-19 B Purchase Dallas Jayson Donald Alexander

President and CEO

Executive Director
3,600 +6.0%
27.56
US$99,209 		3,600 +6.0% 27.56 US$99,209
2018-06-14 2018-06-13 PP Planned purchase
3.3
BJERKHOLT ERIC

Chief Financial Officer
1,600 +8.9%
30.41
US$48,663 		1,600 +8.9% 30.41 US$48,663
2018-06-13 2018-06-11 PlS Planned sale DILLY STEPHEN GEORGE

President and CEO

Executive Director
29,457 -8.5%
30.83
US$908,301 		29,457 -8.5% 30.83 US$908,301
2018-06-08 2018-06-08 PlS Planned sale DILLY STEPHEN GEORGE

President and CEO

Executive Director
42,106 -11.8%
30.70
US$1,292,511 		42,106 -11.8% 30.70 US$1,292,511
2018-06-08 2018-06-07 PlS Planned sale DILLY STEPHEN GEORGE

President and CEO

Executive Director
500 -0.2%
31.58
US$15,790 		500 -0.2% 31.58 US$15,790
2018-06-08 2018-06-07 PlS Planned sale DILLY STEPHEN GEORGE

President and CEO

Executive Director
32,098 -9.2%
30.95
US$993,321 		32,098 -9.2% 30.95 US$993,321
2018-06-08 2018-06-06 PlS Planned sale DILLY STEPHEN GEORGE

President and CEO

Executive Director
30,465 -8.8%
31.20
US$950,371 		30,465 -8.8% 31.20 US$950,371
2018-06-05 2018-06-05 PlS Planned sale DILLY STEPHEN GEORGE

See Remarks

Executive Director
38,825 -11.0%
31.83
US$1,235,835 		38,825 -11.0% 31.83 US$1,235,835
2018-06-05 2018-06-04 PlS Planned sale DILLY STEPHEN GEORGE

See Remarks

Executive Director
2,612 -0.8%
32.74
US$85,519 		2,612 -0.8% 32.74 US$85,519
2018-06-05 2018-06-04 PlS Planned sale DILLY STEPHEN GEORGE

See Remarks

Executive Director
62,740 -16.5%
31.84
US$1,997,836 		62,740 -16.5% 31.84 US$1,997,836
2018-06-05 2018-06-01 PlS Planned sale DILLY STEPHEN GEORGE

See Remarks

Executive Director
2,498 -0.8%
33.19
US$82,899 		2,498 -0.8% 33.19 US$82,899
2018-06-05 2018-06-01 PlS Planned sale DILLY STEPHEN GEORGE

See Remarks

Executive Director
58,699 -15.6%
32.59
US$1,913,094 		58,699 -15.6% 32.59 US$1,913,094
2018-05-24 2018-05-22 PlS Planned sale Sheehy Douglas T.

See Remarks

Officer
1,648 -4.7%
33.00
US$54,384 		1,648 -4.7% 33.00 US$54,384
2018-05-24 2018-05-22 PlS Planned sale Sheehy Douglas T.

See Remarks

Officer
1,648 -4.7%
33.00
US$54,384 		1,648 -4.7% 33.00 US$54,384
2018-03-06 2018-03-05 PlS Planned sale Sheehy Douglas T.

See Remarks
700 -2.1%
36.60
US$25,618 		700 -2.1% 36.60 US$25,618
2018-03-06 2018-03-05 PlS Planned sale Sheehy Douglas T.

See Remarks
948 -2.8%
35.52
US$33,674 		948 -2.8% 35.52 US$33,674
2018-03-06 2018-03-05 PlS Planned sale Sheehy Douglas T.

See Remarks
1,875 -5.5%
37.00
US$69,375 		1,875 -5.5% 37.00 US$69,375
2018-03-05 2018-03-01 PlS Planned sale Rozenman Mary M.

See Remarks
1,807 -93.3%
33.10
US$59,812 		1,807 -93.3% 33.10 US$59,812
2020-04-24 2018-02-26 B Purchase
Nestle Health Science US Holdings, Inc.
Large shareholder
937,500 +12.4%
32.00
US$30,000,000 		937,500 +12.4% 32.00 US$30,000,000
2018-02-26 2018-02-26 B Purchase BJERKHOLT ERIC

Chief Financial Officer

Officer
3,125 +62.5%
32.00
US$100,000 		3,125 +62.5% 32.00 US$100,000
2018-02-26 2018-02-26 B Purchase FALBERG KATHRYN E Non-Executive Director
30,000 +31.6%
32.00
US$960,000 		30,000 +31.6% 32.00 US$960,000
2018-02-26 2018-02-26 B Purchase Iwicki Mark T Non-Executive Director
9,375 +46.9%
32.00
US$300,000 		9,375 +46.9% 32.00 US$300,000
2018-02-26 2018-02-22 B Purchase ENRIGHT PATRICK G Non-Executive Director Large shareholder
15,593 +214.3%
32.00
US$498,976 		15,593 +214.3% 32.00 US$498,976
2018-02-26 2018-02-22 B Purchase Tammenoms Bakker Juliet Large shareholder
9,375 +128.8%
32.00
US$300,000 		9,375 +128.8% 32.00 US$300,000
2018-02-07 2018-02-05 PlS Planned sale Sheehy Douglas T.

See Remarks

Officer
1,648 -100.0%
35.87
US$59,114 		1,648 -100.0% 35.87 US$59,114
2018-02-05 2018-02-01 PlS Planned sale Rozenman Mary M.

See Remarks

Officer
4,292 -97.1%
35.58
US$152,703 		4,292 -97.1% 35.58 US$152,703
2018-02-05 2018-02-01 PlS Planned sale Rozenman Mary M.

See Remarks

Officer
2,300 -34.2%
34.95
US$80,385 		2,300 -34.2% 34.95 US$80,385
2018-01-26 2018-01-24 PlS Planned sale Sheehy Douglas T.

See Remarks

Officer
1,875 -100.0%
38.15
US$71,531 		1,875 -100.0% 38.15 US$71,531
2018-01-16 2018-01-16 PlS Planned sale ADELMAN DANIEL C MD

Chief Medical Officer

Officer
9,933 -100.0%
40.00
US$397,320 		9,933 -100.0% 40.00 US$397,320
2018-01-16 2018-01-12 PlS Planned sale ADELMAN DANIEL C MD

Chief Medical Officer

Officer
26,784 -100.0%
40.00
US$1,071,360 		26,784 -100.0% 40.00 US$1,071,360
2018-01-08 2018-01-04 PlS Planned sale Sheehy Douglas T.

See Remarks

Officer
1,648 -100.0%
37.33
US$61,520 		1,648 -100.0% 37.33 US$61,520
2018-01-04 2018-01-02 PlS Planned sale Barrowcliffe Susan E.

General Manager, Europe

Officer
600 -100.0%
37.75
US$22,652 		600 -100.0% 37.75 US$22,652
2018-01-04 2018-01-02 PlS Planned sale Barrowcliffe Susan E.

General Manager, Europe

Officer
24,400 -97.6%
37.12
US$905,716 		24,400 -97.6% 37.12 US$905,716
2018-01-04 2018-01-02 PlS Planned sale Barrowcliffe Susan E.

General Manager, Europe

Officer
300 -1.2%
37.86
US$11,359 		300 -1.2% 37.86 US$11,359
2018-01-04 2018-01-02 PlS Planned sale Barrowcliffe Susan E.

General Manager, Europe

Officer
24,700 -49.4%
37.13
US$917,022 		24,700 -49.4% 37.13 US$917,022
2018-01-04 2018-01-02 PlS Planned sale Barrowcliffe Susan E.

General Manager, Europe

Officer
599 -1.2%
37.78
US$22,629 		599 -1.2% 37.78 US$22,629
2018-01-04 2018-01-02 PlS Planned sale Barrowcliffe Susan E.

General Manager, Europe

Officer
24,401 -32.5%
37.12
US$905,811 		24,401 -32.5% 37.12 US$905,811
2018-01-04 2018-01-02 PlS Planned sale Rozenman Mary M.

See Remarks

Officer
1,601 -92.5%
37.08
US$59,367 		1,601 -92.5% 37.08 US$59,367
2018-01-04 2018-01-02 PlS Planned sale Rozenman Mary M.

See Remarks

Officer
4,990 -74.3%
37.12
US$185,223 		4,990 -74.3% 37.12 US$185,223
2017-12-29 2017-12-27 PlS Planned sale ADELMAN DANIEL C MD

Chief Medical Officer
3,283 -100.0%
40.00
US$131,320 		3,283 -100.0% 40.00 US$131,320
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
3,600 -96.5%
39.15
US$140,949 		3,600 -96.5% 39.15 US$140,949
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
6,400 -63.2%
38.73
US$247,848 		6,400 -63.2% 38.73 US$247,848
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
1,200 -10.6%
39.28
US$47,134 		1,200 -10.6% 39.28 US$47,134
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
8,800 -43.7%
38.83
US$341,663 		8,800 -43.7% 38.83 US$341,663
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
700 -3.4%
39.26
US$27,479 		700 -3.4% 39.26 US$27,479
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
4,310 -17.1%
38.80
US$167,239 		4,310 -17.1% 38.80 US$167,239
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
1,500 -5.6%
39.23
US$58,847 		1,500 -5.6% 39.23 US$58,847
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
11,000 -29.2%
38.82
US$427,043 		11,000 -29.2% 38.82 US$427,043
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
1,500 -3.8%
39.25
US$58,875 		1,500 -3.8% 39.25 US$58,875
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
11,000 -21.9%
38.83
US$427,115 		11,000 -21.9% 38.83 US$427,115
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
1,800 -3.5%
39.23
US$70,605 		1,800 -3.5% 39.23 US$70,605
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
10,700 -17.1%
38.82
US$415,322 		10,700 -17.1% 38.82 US$415,322
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
1,500 -2.3%
39.25
US$58,878 		1,500 -2.3% 39.25 US$58,878
2017-12-28 2017-12-26 PlS Planned sale Rozenman Mary M.

See Remarks
11,000 -14.6%
38.83
US$427,089 		11,000 -14.6% 38.83 US$427,089
2017-12-28 2017-12-26 PlS Planned sale Sheehy Douglas T.

See Remarks
1,875 -100.0%
39.44
US$73,950 		1,875 -100.0% 39.44 US$73,950
2017-12-06 2017-12-04 PlS Planned sale Sheehy Douglas T.

See Remarks
1,906 -100.0%
38.66
US$73,686 		1,906 -100.0% 38.66 US$73,686
Explore more

More insider trading research around Aimmune Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America